Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Prognostic impact of MUM1 expression by immunohistochemistry on primary mediastinal large B-cell lymphoma.

De Mello CA, De Andrade VP, De Lima VC, Carvalho AL, Soares FA.

Leuk Lymphoma. 2011 Aug;52(8):1495-503. doi: 10.3109/10428194.2011.573032. Epub 2011 May 31.

PMID:
21623692
2.

Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP.

Nyman H, Jerkeman M, Karjalainen-Lindsberg ML, Banham AH, Leppä S.

Mod Pathol. 2009 Aug;22(8):1094-101. doi: 10.1038/modpathol.2009.73. Epub 2009 May 15.

3.

Immunophenotyping of diffuse large B-cell lymphoma (DLBCL) defines multiple sub-groups of germinal centre-like tumours displaying different survival characteristics.

Anderson JJ, Fordham S, Overman L, Dignum H, Wood K, Proctor SJ, Crosier S, Angus B, Culpin RE, Mainou-Fowler T.

Int J Oncol. 2009 Nov;35(5):961-71.

PMID:
19787248
4.

Prognostic evaluation of immunohistochemical profiles in diffuse large B-cell lymphoma: a Chinese study.

Chen Z, Du Z, Chen J, Chen Z, Bao Y, Tang F.

Med Oncol. 2011 Mar;28(1):241-8. doi: 10.1007/s12032-010-9433-3. Epub 2010 Feb 18.

PMID:
20165991
5.

Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma.

Muris JJ, Meijer CJ, Vos W, van Krieken JH, Jiwa NM, Ossenkoppele GJ, Oudejans JJ.

J Pathol. 2006 Apr;208(5):714-23.

PMID:
16400625
6.

Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma.

Chang CC, McClintock S, Cleveland RP, Trzpuc T, Vesole DH, Logan B, Kajdacsy-Balla A, Perkins SL.

Am J Surg Pathol. 2004 Apr;28(4):464-70.

PMID:
15087665
7.

Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype.

Yoshida S, Nakamura N, Sasaki Y, Yoshida S, Yasuda M, Sagara H, Ohtake T, Takenoshita S, Abe M.

Mod Pathol. 2005 Mar;18(3):398-405.

8.

T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.

Gualco G, Weiss LM, Barber GN, Bacchi CE.

Hum Pathol. 2010 Sep;41(9):1238-44. doi: 10.1016/j.humpath.2010.01.015. Epub 2010 Apr 10.

PMID:
20382409
9.

Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.

van Imhoff GW, Boerma EJ, van der Holt B, Schuuring E, Verdonck LF, Kluin-Nelemans HC, Kluin PM.

J Clin Oncol. 2006 Sep 1;24(25):4135-42.

10.

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis.

Berglund M, Thunberg U, Amini RM, Book M, Roos G, Erlanson M, Linderoth J, Dictor M, Jerkeman M, Cavallin-Ståhl E, Sundström C, Rehn-Eriksson S, Backlin C, Hagberg H, Rosenquist R, Enblad G.

Mod Pathol. 2005 Aug;18(8):1113-20.

11.

Nodal diffuse large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome.

Gualco G, Weiss LM, Harrington WJ Jr, Bacchi CE.

Am J Surg Pathol. 2009 Dec;33(12):1815-22. doi: 10.1097/PAS.0b013e3181bb9a18.

12.

Fas and Fas ligand expression on germinal center type-diffuse large B-cell lymphoma is associated with the clinical outcome.

Kojima Y, Tsurumi H, Goto N, Shimizu M, Kasahara S, Yamada T, Kanemura N, Hara T, Sawada M, Saio M, Yamada T, Takahashi T, Tomita E, Takami T, Moriwaki H.

Eur J Haematol. 2006 Jun;76(6):465-72. Epub 2006 Feb 23.

PMID:
16494623
13.

Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era.

Seki R, Ohshima K, Fujisaki T, Uike N, Kawano F, Gondo H, Makino S, Eto T, Moriuchi Y, Taguchi F, Kamimura T, Tsuda H, Ogawa R, Shimoda K, Yamashita K, Suzuki K, Suzushima H, Tsukazaki K, Higuchi M, Utsunomiya A, Iwahashi M, Imamura Y, Tamura K, Suzumiya J, Yoshida M, Abe Y, Matsumoto T, Okamura T.

Cancer Sci. 2009 Oct;100(10):1842-7. doi: 10.1111/j.1349-7006.2009.01268.x. Epub 2009 Jul 1.

14.

Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma.

Xie X, Sundram U, Natkunam Y, Kohler S, Hoppe RT, Kim YH, Cook JR, Hammel J, Swerdlow SH, Guitart J, Smith MD, Bosler D, Listinsky C, Lossos IS, Hsi ED.

Mod Pathol. 2008 Jun;21(6):653-9. doi: 10.1038/modpathol.2008.30. Epub 2008 Feb 8.

15.

Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis.

Bodoor K, Matalka I, Hayajneh R, Haddad Y, Gharaibeh W.

Asian Pac J Cancer Prev. 2012;13(7):3037-46.

16.

SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma.

Jang KY, Hwang SH, Kwon KS, Kim KR, Choi HN, Lee NR, Kwak JY, Park BH, Park HS, Chung MJ, Kang MJ, Lee DG, Kim HS, Shim H, Moon WS.

Am J Surg Pathol. 2008 Oct;32(10):1523-31. doi: 10.1097/PAS.0b013e31816b6478.

PMID:
18724249
17.

Most primary central nervous system diffuse large B-cell lymphomas occurring in immunocompetent individuals belong to the nongerminal center subtype: a retrospective analysis of 31 cases.

Hattab EM, Martin SE, Al-Khatib SM, Kupsky WJ, Vance GH, Stohler RA, Czader M, Al-Abbadi MA.

Mod Pathol. 2010 Feb;23(2):235-43. doi: 10.1038/modpathol.2009.164. Epub 2009 Nov 20.

19.

Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: A study of 18 cases.

Al-Abbadi MA, Hattab EM, Tarawneh MS, Amr SS, Orazi A, Ulbright TM.

Mod Pathol. 2006 Dec;19(12):1521-7. Epub 2006 Sep 22.

20.

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC.

Blood. 2004 Jan 1;103(1):275-82. Epub 2003 Sep 22.

Items per page

Supplemental Content

Write to the Help Desk